Tarus Therapeutics, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2019-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://tarustx.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)TT-4 As a Single Agent in Subjects with Advanced Selected Solid Tumors
Phase 1
Withdrawn
- Conditions
- Colorectal CancerGastric CancerHepatocellular CarcinomaPancreatic Cancer
- Interventions
- First Posted Date
- 2021-07-26
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Tarus Therapeutics, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT04976660
News
No news found